Under construction – not a live service
Sign in

2022-500906-17-01RecruitingPhase 2

INVITED trial

INfluenza VaccInation To mitigate typE 1 Diabetes (INVITED trial)

Source: EU CTIS (euclinicaltrials.eu) · Last updated 7 Sept 2026

Next steps

Brief summary (registry, in English)

To determine whether or not influenza vaccination will preserve β cell function in early type 1 diabetes mellitus.

Status (registry)
Recruiting
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
100 (estimated)
First submitted
24 Jun 2022
Start date
21 Mar 2023
Lead sponsor
Aarhus University Hospital
EU CT number
2022-500906-17-01

What you commit to

  • Study type: Interventional · Phase 2
  • Planned participants: 100
  • 10 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Severe allergy to eggs or previous allergic reaction to influenza vaccine.
  • Previous randomization in the INVITED trial.

Other illness

  • Strong indication for influenza vaccination for non-diabetic disease.
  • Suspicion of febrile illness or acute, ongoing infection.
  • Hypersensitivity to the active substances or ingredients of Vaxigrip Tetra or against any residues, such as eggs (ovalbumin or chicken proteins), neomycin, formaldehyde and octoxinol.

Age

  • Age <7 or ≥18 years.

Other

  • Influenza vaccination during the current influenza season (September 1 – March 1).
  • Patients with endogenic or iatrogenic immunosuppression that may result in reduced immunization response.
  • Inability to provide informed consent.

Who the study is looking for

  • Patients hospitalized with newly diagnosed type 1 diabetes mellitus.
  • Male or female subjects ≥7 and <18 years.
  • Written informed consent (parents, legal guardian).

Age in the registry: - to 17 years · Sex: All · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (10)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Aalborg University HospitalAalborgDenmarkRecruiting
Aarhus UniversityAarhus NDenmarkRecruiting
Steno Diabetes Center CopenhagenHerlevDenmarkRecruiting
Region MidtjyllandHerningDenmarkRecruiting
Holbaek SygehusHolbækDenmarkRecruiting
Nykoebing F SygehusNykobing FDenmarkRecruiting
Regionshospitalet RandersRanders NøDenmarkRecruiting
Region SjaellandRoskildeDenmarkRecruiting
Slagelse HospitalSlagelseDenmarkRecruiting
Region MidtjyllandViborgDenmarkRecruiting

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.